SOURCE: Wall Street News Alert

August 03, 2006 09:08 ET

Stock Watch: Small Public Company Has Been Granted Its Fourth Patent From the U.S. Patent Office! August 3, 2006

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding.

WESTON, FL -- (MARKET WIRE) -- August 3, 2006 -- Wall Street News Alert's "stocks to watch" this morning are: Human Biosystems (OTCBB: HBSC), St. Jude Medical, Inc. (NYSE: STJ), Merck & Co., Inc. (NYSE: MRK) and Amgen (NASDAQ: AMGN).

Once again, Human Biosystems (OTCBB: HBSC) may be a target of aggressive investors and day traders this morning! Yesterday after the stock markets closed, the company, a developer of preservation platforms for organs and other biomaterials, issued a press release announcing that it has been granted its fourth patent from the U.S. Patent Office. Patent #7,083,910.

News of the new patent may be of interest to investors! "Preservation of Blood Platelets with Citrate" should greatly contribute in the area of blood platelet preservation for the two major recipient groups of blood platelets: cancer patients that have undergone chemotherapy and/or radiation treatment (about 70%), and trauma patients suffering from extensive bleeding.

Blood platelets are the congealing component in blood. Before platelets can be released to the medical community for use by human patients, they must undergo a number of tests to assure their purity, which can take one to two days to complete. Then they must be transported to the medical facilities which can add more time. Thus, there is a very limited shelf-life left for these platelets once they are available for use.

Current technology provides for the storage of platelets at room temperature. This allows any bacteria present to grow rapidly over the current 5-day allowable shelf period. The extra storage days possible with the use of the HBS cold storage method should provide a dramatic decrease in the cost and the waste that is inherent in the current blood platelet storage methodology. It should also help keep blood platelets more bacteria free.

Wall Street News Alert is continuing to place Aggressive Investors on alert to monitor the progress of Human Biosystems! "Our newest patent covers the process of cooling blood platelets to near zero degrees Centigrade to keep them fresh and preserved for greater than the current standard of 5 days. We anticipate being able to extend this process to 7 days and beyond. This will reduce the current need to discard stored platelets that have been preserved by existing methods. By developing a cooling method that prolongs the preservation of platelets, we believe this will greatly reduce the risk of bacterial infection while increasing the availability of essential medical resources required to treat cancer and trauma patients," explained Dr. David Winter, President of Human BioSystems.

In the past month Human BioSystems has announced the completion of the second independent test of their blood platelet preservation technology and their preparation for application to the FDA for a license to begin human testing.

Prior to the latest press release, the stock closed yesterday at Eighteen cents a share.

For an in-depth profile of Human Biosystems, visit

Human BioSystems is a developer of preservation platforms for organs and other biomaterials. The Company, which is headquartered in Palo Alto, California with research facilities in Michigan, has made significant progress in its nine-year history. This fourth patent is another milestone for Human BioSystems. HBS also announced recently the signing of a letter of intent to enter the BioFuels business through the acquisition of two ethanol production facility projects from EXL III. In a press release, the company stated that it made the decision to enter the bio energy field because it gives HBS the potential to achieve substantial revenue and profit growth within a predictable timetable and that the acquisition should give HBS additional financing options not previously available.

To view all of Wall Street News Alert's special early morning trading alerts for this morning, visit, where you may also sign up to receive free email alerts in advance of our press releases being issued.

St. Jude Medical, Inc. (NYSE: STJ) up 1.1% on 10.6 million shares traded. St. Jude Medical is dedicated to making life better for cardiac, neurological and chronic pain patients worldwide through excellence in medical device technology and services.

Merck & Co., Inc. (NYSE: MRK) up 0.5% on 10.2 million shares traded. Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first.

Amgen (NASDAQ: AMGN) up 1% on 9 million shares traded. Amgen discovers, develops and delivers innovative human therapeutics.

Market Commentary:

"On the economic front, the Commerce Department said that consumer spending, two-thirds of GDP, is up by 0.4% in June after a 0.6% rise in May, the smallest gain in a year. Elsewhere, construction spending is up in June by 0.3%, the highest in 3 months," stated Sonja Rudd in Wall Street News Alert's daily commentary continued at:

Let Wall Street News Alert help advertise for your company using our effective awareness campaigns. If you're Interested in telling your story, we can help. Contact us at

WSNA's email alert service is free to those investors who sign up on the WSNA home page. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to Special Situation companies that have the potential of showing increased activity. The Wall Street News Alert home page has experienced over 50 million hits. To subscribe to this free service, visit the Wall Street News Alert home page at and select the "join now" button.

WSNA is a Platinum Sponsor of Quality Stocks. Quality Stocks tracks the stock picks of 150 Investment Newsletters every day and reports on their performance. For their free service, visit

*** It has come to the attention of Wall Street News Alert (WSNA), that various persons or companies distribute faxes bearing similar names to Wall Street News Alert. Wall Street News Alert is not affiliated with faxes bearing names such as: Wall Street Stock Alert, Wall Street Investor Alert, Wall Street News Alert or any other fax using various combinations of the generic words Wall Street.***

Wall Street News Alert is a division of Wall Street Capital Funding LLC (WSCF). WSCF also maintains a contractual, working relationship with Stock Market Alerts LLC and its' Wall Street Enews brand. WSCF is not a registered broker/dealer and may not sell, offer to sell or offer to buy any security. WSCF profiles are not a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational. The companies that are discussed in this release have not approved the statements made in this release nor approved the timing of this release. All statements and expressions are the sole opinion of WSCF and are subject to change without notice. Information in this release is derived from a variety of sources including that company's publicly disseminated information, third parties and WSCF research. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. WSCF disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. The release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. WSCF is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment if they make a purchase in WSCF profiled stocks.

This profile is not without bias, and is a paid release. WSCF has been compensated for dissemination of company information on behalf of one or more of the companies mentioned in this release. WSCF has been compensated Fourteen Thousand Dollars for current coverage AND was previously compensated Thirty Eight Thousand Dollars for past coverage of Human Biosystems (OTCBB: HBSC), by the company, for services provided including dissemination of company information in this release. WSCF holds no shares of the stock. WSCF may receive additional compensation for extension of its services. Any additional compensation will be disclosed at such time that WSCF is aware of a clients desire to extend the original services. WSCF may have received shares of a company profiled in this release prior to the dissemination of the information in this release. WSCF may immediately sell some or any shares in a profiled company held by WSCF and may have previously sold shares in a profiled company held by WSCF. WSCF's services for a company may cause the company's stock price to increase, in which event WSCF would make a profit when it sells its stock in a company. In addition, WSCF's selling of a company's stock may have a negative effect on the market price of the stock.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and WSCF undertakes no obligation to update such statements.

Contact Information